Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition) ›› 2017, Vol. 03 ›› Issue (02): 138-142. doi: 10.3877/cma.j.issn.2096-1537.2017.02.012

Special Issue: Critical care medicine

• Opinion • Previous Articles     Next Articles

Hyperamylasemia and/or hyperlipasemia in ICU: acute pancreatitis?

Dongya Huang1, Yi Miao1, Kuirong Jiang1, Qiang Li1,()   

  1. 1. Department of Pancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
  • Received:2016-10-24 Online:2017-05-28 Published:2017-05-28
  • Contact: Qiang Li
  • About author:
    Corresponding author: Li Qiang, Email:

Abstract:

Hyperamylasemia and hyperlipasemia are frequently encountered in critically ill patients. Elevation in serum levels of pancreatic enzymes (hyperamylasemia and/or hyperlipasemia) can occur in any Intensive Care Unit (ICU) patient either as a result of true acute pancreatitis (AP) or as a manifestation of a nonpancreatic disease. On the one hand, AP can be misdiagnosed because neither amylase nor lipase is specific for pancreatitis. On the other hand, it is often not possible to discriminate true pancreatitis from complex and severe patients. It is essential to understand different non-pancreatic conditions where there is elevation of pancreatic enzymes and to identify true AP in critically ill patients without typical clinical features.

Key words: Intensive care, Hyperamylasemia, Lipase, Pancreatitis

京ICP 备07035254号-19
Copyright © Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), All Rights Reserved.
Tel: 010-51322627 E-mail: ccm@cma.org.cn
Powered by Beijing Magtech Co. Ltd